Subdural hematoma in patients with systemic cancer.
We reviewed the medical records of 70 patients with systemic cancer in whom a subdural hematoma (SDH) developed. Among patients with a solid tumor, trauma and use of anticoagulants were common causes of SDH, and these patients had a relatively favourable outcome. Among patients with a hematologic cancer and in the rest of the patients with a solid tumor, coagulopathies and dural metastatic involvement were the most common causes of SDH. Recurrent SDH and death due to SDH were common in the latter group.
Minette
S E
SE
Department of Neurology, Mayo Clinic, Rochester, MN 55905.
Kimmel
D W
DW
D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects*; D006259:Craniocerebral Trauma / Q000150:complications*; D005260:Female; D006408:Hematoma, Subdural / Q000209:etiology* / Q000601:surgery; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications; D008297:Male; D008577:Meningeal Neoplasms / Q000150:complications / Q000556:secondary; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D012008:Recurrence; D012307:Risk Factors
D000925:Anticoagulants